News Image

BridgeBio Announces Publication of Case Study Exploring Portfolio Theory’s Impact on Biomedical Innovation in The Journal of Portfolio Management

Provided By GlobeNewswire

Last update: Nov 5, 2024

- Case study co-authored by members of BridgeBio senior management and BridgeBio co-founder and MIT professor, Andrew W. Lo, Ph.D.

- Case study features BridgeBio’s unique model that uses portfolio theory to enable early-stage research for genetic diseases and conditions that are not typically addressed by the pharmaceutical industry

Read more at globenewswire.com

BRIDGEBIO PHARMA INC

NASDAQ:BBIO (2/21/2025, 8:02:48 PM)

After market: 36.85 0 (0%)

36.85

+0.05 (+0.12%)



Find more stocks in the Stock Screener

Follow ChartMill for more